Dr. Goldberg received his PhD in 2008 from MIT, where he worked in the laboratory of Institute Professor Robert Langer. He subsequently pursued post-doctoral training under the supervision of Institute Professor Philip Sharp at MIT. In 2012, he became assistant professor of Microbiology and Immunobiology at Harvard Medical School and in the Department of Cancer Immunology at Dana-Farber Cancer Institute, where he works on the development and delivery of novel therapeutics.
The Goldberg Lab strives to develop and deliver novel therapeutics in order to improve the lives of patients. They combine the tools of synthetic chemistry, molecular biology, materials science, bioengineering, and immunology to address important problems that are intractable from a uni-disciplinary approach. Their single-minded goal is to contribute to the betterment of human health particularly in the realm of cancer.